PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29796168-4	2018	Here, we aimed to elucidate the anti-cancer effects of JQ1 and the mechanisms underlying BRD4 inhibition in sunitinib-sensitive and -resistant ccRCCs.	Sunitinib	108-117	bromodomain containing 4	Homo sapiens	89-93	
29796168-8	2018	Chromatin immunoprecipitation assays revealed that these oncogenes may be promising BRD4 targets, particularly in sunitinib-resistant ccRCC cells.	Sunitinib	114-123	bromodomain containing 4	Homo sapiens	84-88	
29796168-9	2018	These results identified SCG5, SPOCD1, RGS19, and ARHGAP22 as potential prognostic markers and showed that BRD4 inhibition may have applications as a potential therapeutic approach in sunitinib-sensitive and -resistant ccRCC.	Sunitinib	184-193	bromodomain containing 4	Homo sapiens	107-111